Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02718625 · ClinicalTrials.gov registry record · Phase 4
Study of SANTYL® vs Hydrogel (SoloSite®) for Pressure Ulcers
A Phase 4 study, sponsored by Smith & Nephew.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT02718625 is a Phase 4 study that was terminated before completion, run by Smith & Nephew. The registered enrollment target is 3 participants.
The verdict
NCT02718625, a Phase 4 study, was terminated before completion, sponsored by Smith & Nephew.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study is designed to compare SANTYL® versus hydrogel (SoloSite®) in the treatment of pressure ulcers for participants in a long-term care facility. After meeting study criteria, participants will be randomly assigned for application of SANTYL® or SoloSite® to their pressure ulcer for up to 6 weeks. A study previously conducted showed that in the long-term care setting, the removal of dead skin (debridement) with SANTYL® resulted in more participants achieving complete debridement, more rapidly than when SoloSite® is used. The goal of the present study is to confirm the results of the earlier study, demonstrating superior debridement outcomes for pressure ulcers of patients in long-term care as compared to ulcers managed with SoloSite®.
Interventions
- BIOLOGICAL Santyl
- BIOLOGICAL SoloSite®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-03-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02718625
The ClinicalTrials.gov registry entry for NCT02718625 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Smith & Nephew, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Santyl is the first listed.
NCT02718625 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02718625 about?
NCT02718625 is a clinical study titled "Study of SANTYL® vs Hydrogel (SoloSite®) for Pressure Ulcers". This study is designed to compare SANTYL® versus hydrogel (SoloSite®) in the treatment of pressure ulcers for participants in a long-term care facility. After meeting study criteria, participants will be randomly assigned for application of SANTYL® or SoloSite® to their pressure ulcer for up to 6 we...
What is the current status of trial NCT02718625?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2016-08. Estimated completion is 2017-03-09.
What interventions are being tested in trial NCT02718625?
The interventions under investigation include: Santyl (BIOLOGICAL), SoloSite® (BIOLOGICAL).
Who is sponsoring clinical trial NCT02718625?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.